New vaccine aims to arm immune systems against hidden virus in people with HIV
NCT ID NCT05099965
Summary
This study tested whether a new vaccine could safely boost the immune system's ability to fight cytomegalovirus (CMV) in people who also have HIV. The trial involved 90 adults whose HIV was well-controlled with medication. Participants received either two doses of the experimental vaccine or a placebo, and researchers tracked their safety and immune responses for nearly two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alabama CRS
Birmingham, Alabama, 35222, United States
-
Case Clinical Research Site
Cleveland, Ohio, 44106, United States
-
Chapel Hill CRS
Chapel Hill, North Carolina, 27599, United States
-
Houston AIDS Research Team CRS
Houston, Texas, 77009, United States
-
Massachusetts General Hospital CRS (MGH CRS)
Boston, Massachusetts, 02114, United States
-
Penn Therapeutics, CRS
Philadelphia, Pennsylvania, 19104, United States
-
UCLA CARE Center CRS
Los Angeles, California, 90035-4709, United States
-
UCSD Antiviral Research Center
San Diego, California, 92103, United States
-
Ucsf Hiv/Aids Crs
San Francisco, California, 94110, United States
-
University of Colorado Hospital CRS
Aurora, Colorado, 80045, United States
-
University of Pittsburgh CRS
Pittsburgh, Pennsylvania, 15213, United States
-
Washington University Therapeutics (WT) CRS
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.